Breaking News Instant updates and real-time market news.

2019-11-04 08:13:38 S Sprint $6.31 0.085 (1.37%) , TMUS T-Mobile $82.46 -0.21 (-0.25%) 08:13 11/04/19 11/04 08:13 11/04/19 08:13	Sprint CEO says merging with T-Mobile 'best outcome for all consumers' "I am proud of the resiliency of the Sprint team as they work to deliver results in a challenging environment," said Sprint CEO Michel Combes. "However, I remain convinced that merging with T-Mobile and building one of the world's most advanced 5G networks is the best outcome for all consumers, employees, and shareholders." S Sprint $6.31 0.085 (1.37%) TMUS T-Mobile $82.46 -0.21 (-0.25%)	04 Nov 05 Nov 18 Nov 09 Dec
S TMUS S Sprint $6.31 0.085 (1.37%) 10/04/19 SBSH 10/04/19 NO CHANGE Target $40 SBSH Buy Value of Dish assets higher than current share price, says Citi Citi analyst Michael Rollins recommends buying shares of Dish (DISH). He keeps a Buy rating on the stock with a price target of $40, down from $42. Dish has accumulated assets that retain higher value to wireless network operators, video distributors, and wireless mobile virtual network operators than what is currently encapsulated in the share price, Rollins tells investors in a research note. Further, the analyst views the proposed merger of T-Mobile (TMUS) and Sprint (S) as a "catalyst for change." If the deal gets done, Dish is likely to move further down the operating path and potentially attract new partners, says the analyst. If the deal doesn't get done, the likelihood rises that Dish needs to assertively partner or sell assets, Rollins adds. 10/10/19 MSCO 10/10/19 NO CHANGE MSCO Tower leasing demand looks to be softening, says Morgan Stanley Morgan Stanley analyst Simon Flannery said that about 40% of the 20+ private tower owners he surveyed said they see decreased leasing demand in Q3, with some indicating that T-Mobile (TMUS) appears to be on hold until year end as it works on closing its deal for Sprint (S). The respondents in his survey expect an average organic growth rate of about 8% in 2019, which is down from over 10% last quarter but compares favorably to the 6% he currently estimates for American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC), Flannery tells investors. The analyst said he expects reported Q3 results to be solid, but slower leasing activity could begin to impact tower owners' results in 2020. 10/29/19 RHCO 10/29/19 NO CHANGE Target $95 RHCO Buy T-Mobile price target raised to $95 from $80 at SunTrust SunTrust analyst Greg Miller raised his price target on T-Mobile (TMUS) to $95 and kept his Buy rating, saying the company's Q3 results continue to "demonstrate strength" of its "UnCarrier strategy" and its ability to capture market share in a more "competitive and mature" market place. The analyst further states that he remains optimistic that the company's can close its Sprint (S) merger with only an approval by federal regulators and contends that T-Mobile remains among "best" in the space. 11/01/19 COWN 11/01/19 NO CHANGE Target $260 COWN Outperform American Tower price target raised to $260 from $238 at Cowen Cowen analyst Colby Synesael raised his price target on American Tower (AMT) to $260 from $238 following in-line Q3 results. The analyst said the recent India situation as well as the pending T-Mobile (TMUS)/Sprint (S) merger creates near-term uncertainty but he views the recent selloff as a buying opportunity. He expects more meaningful upside in 2020 when the India and merger situations are resolved. Synesael maintained his Outperform rating on American Tower shares. TMUS T-Mobile $82.46 -0.21 (-0.25%) 10/29/19 COWN 10/29/19 NO CHANGE Target $87 COWN Outperform T-Mobile price target lowered to $87 from $93 at Cowen Cowen analyst Colby Synesael lowered his price target on T-Mobile to $87 from $93 following good Q3 results and raised 2019 postpaid net adds/EBITDA. The analyst said momentum continues on market segmentation and network improvement but he feels the near-term upside is limited although he would be a buyer on any weakness. Synesael reiterated his Outperform rating on T-Mobile shares. 11/04/19 NOMU 11/04/19 DOWNGRADE Target $65 NOMU Neutral Nomura Instinet downgrades Verizon to Neutral after AT&T price cuts Nomura Instinet analyst Jeffrey Kvaal downgraded Verizon Communications (VZ) to Neutral from Buy with a price target of $65, down from $67. The stock closed Friday down 11c to $60.37. AT&T's (T) new price reductions, and T-Mobile's (TMUS) likely response, reduces visibility into Verizon's near-term growth trajectory, Kvaal tells investors in a research note. The analyst now has lower confidence into Verizon's long-term ability to lift pricing for 5G. While he prefers wireless over fixed over time, he moves to a Neutral stance on Verizon.

2019-11-04 08:13:38

Sprint

$6.31: 0.085 (1.37%)

, TMUS

T-Mobile

$82.46: -0.21 (-0.25%)

08:13

11/04/19

11/04

08:13

11/04/19

08:13

Sprint CEO says merging with T-Mobile 'best outcome for all consumers'

"I am proud of the resiliency of the Sprint team as they work to deliver results in a challenging environment," said Sprint CEO Michel Combes. "However, I remain convinced that merging with T-Mobile and building one of the world's most advanced 5G networks is the best outcome for all consumers, employees, and shareholders."

Sprint

$6.31: 0.085 (1.37%)

TMUS

T-Mobile

$82.46: -0.21 (-0.25%)

04
Nov
05
Nov
18
Nov
09
Dec

S
TMUS

S Sprint

$6.31: 0.085 (1.37%)

10/04/19: SBSH

10/10/19: MSCO

10/29/19: RHCO

11/01/19: COWN

TMUS T-Mobile

$82.46: -0.21 (-0.25%)

10/29/19: COWN

11/04/19: NOMU

TODAY'S FREE FLY STORIES

EMN Eastman Chemical $75.68 0.67 (0.89%) 16:43 12/05/19 12/05 16:43 12/05/19 16:43 Hot Stocks	Eastman Chemical raises quarterly dividend 6.5% to 66c from 62c per share » The dividend is payable… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EVRI Everi Holdings $11.86 -1 (-7.78%) 16:43 12/05/19 12/05 16:43 12/05/19 16:43 Syndicate	Everi Holdings 10M share Secondary priced at $11.25 » The deal priced below the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 06 Dec
ZUMZ Zumiez $30.63 0.67 (2.24%) 16:39 12/05/19 12/05 16:39 12/05/19 16:39 Earnings	Zumiez raises FY19 SSS growth view to 4.0%-4.5% from prior view 2.0%-4.0% » Based upon better than… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 05 Dec
CRWD Crowdstrike $53.00 -2.04 (-3.71%) 16:38 12/05/19 12/05 16:38 12/05/19 16:38 Earnings	Crowdstrike raises FY20 EPS view to (53c)-(52c) from (65c)-(62c) » Consensus (63c). Raises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 12 Dec
FNHC Federated National $15.37 -0.04 (-0.26%) 16:36 12/05/19 12/05 16:36 12/05/19 16:36 Hot Stocks	Federated National announces new $10M share repurchase program » Federated National… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

CRWD Crowdstrike $53.00 -2.04 (-3.71%) 16:36 12/05/19 12/05 16:36 12/05/19 16:36 Earnings	Crowdstrike sees Q4 adjusted EPS (9c)-(8c), consensus (11c) » Sees Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 12 Dec
CRWD Crowdstrike $53.00 -2.04 (-3.71%) 16:35 12/05/19 12/05 16:35 12/05/19 16:35 Earnings	Crowdstrike reports Q3 adjusted EPS (7c), consensus (11c) » Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 12 Dec
EPZM Epizyme $15.32 -0.48 (-3.04%) 16:35 12/05/19 12/05 16:35 12/05/19 16:35 Upgrade	Epizyme rating change » Epizyme upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec 18 Dec 23 Jan
ESTA Establishment Labs $24.31 0.32 (1.33%) 16:35 12/05/19 12/05 16:35 12/05/19 16:35 Hot Stocks	Establishment Labs reaches one million Motiva implants milestone » Establishment Labs… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
IDT IDT Corp $7.47 0.26 (3.61%) 16:34 12/05/19 12/05 16:34 12/05/19 16:34 Earnings	IDT Corp reports Q1 EPS 10c vs. (2c) last year » Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 12 Dec

KODK Kodak $2.59 0.085 (3.39%) 16:33 12/05/19 12/05 16:33 12/05/19 16:33 Hot Stocks	Kodak's Karfunkel acquires over 4.4M common shares » In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PAC GAP Airports $99.66 -1.12 (-1.11%) 16:32 12/05/19 12/05 16:32 12/05/19 16:32 Hot Stocks	GAP Airports reports November traffic up 10.1% » GAP Airports announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
JOE Saint Joe Co. $19.49 0.7 (3.73%) 16:32 12/05/19 12/05 16:32 12/05/19 16:32 Hot Stocks	St. Joe, HomeCorp to build additional 120 apartment homes in Panama City Beach » The St. Joe Company and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ALEC Alector $19.44 -0.17 (-0.87%) 16:32 12/05/19 12/05 16:32 12/05/19 16:32 Hot Stocks	Alector announces FDA fast track designation granted to AL001 for dementia » Alector announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MGLN Magellan Health $76.79 -0.12 (-0.16%) 16:31 12/05/19 12/05 16:31 12/05/19 16:31 Hot Stocks	Magellan Health names James Murray as President and COO » Magellan Health announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

SWIR Sierra Wireless $9.15 0.12 (1.33%) 16:31 12/05/19 12/05 16:31 12/05/19 16:31 Hot Stocks	Sierra Wireless CFO Dave McLennan retiring in mid-2020 » Sierra Wireless CFO Dave… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Feb
ASR Asur $167.79 -1.88 (-1.11%) 16:30 12/05/19 12/05 16:30 12/05/19 16:30 Hot Stocks	Asur reports total November passenger traffic up 7.3% » Asur announced that total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AXNX Axonics $25.05 0.92 (3.81%) 16:30 12/05/19 12/05 16:30 12/05/19 16:30 Hot Stocks	Integrated Core Strategies reports 5.1% passive stake in Axonics » Integrated Core… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
COO Cooper Companies $313.10 1 (0.32%) 16:30 12/05/19 12/05 16:30 12/05/19 16:30 Earnings	Cooper Companies sees Q1 EPS $2.65-$2.75, consensus $2.97 » Sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 12 Dec 13 Dec
16:30 12/05/19 12/05 16:30 12/05/19 16:30 Options	Preliminary option volume of 14.7M today » Preliminary option volume… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial

COO Cooper Companies $312.96 0.86 (0.28%) 16:28 12/05/19 12/05 16:28 12/05/19 16:28 Earnings	Cooper Companies sees FY20 EPS $12.60-$13.30, consensus $13.10 » Sees FY20 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 12 Dec 13 Dec
BOLD Audentes Therapeutics $59.19 -0.09 (-0.15%) , ALPMY Astellas Pharma $0.00 (0.00%) 16:27 12/05/19 12/05 16:27 12/05/19 16:27 Downgrade	Audentes Therapeutics, Astellas Pharma rating change » Audentes Therapeutics… BOLD Audentes Therapeutics $59.19 -0.09 (-0.15%) ALPMY Astellas Pharma $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec
ZUMZ Zumiez $30.63 0.67 (2.24%) 16:27 12/05/19 12/05 16:27 12/05/19 16:27 Earnings	Zumiez provides Q4 quarter to date sales update » With the Thanksgiving… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 05 Dec
ZUMZ Zumiez $30.63 0.67 (2.24%) 16:26 12/05/19 12/05 16:26 12/05/19 16:26 Earnings	Zumiez sees FY19 EPS $2.38- $2.46, consensus $2.16 » Based upon better than… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 05 Dec
COO Cooper Companies $312.96 0.86 (0.28%) 16:25 12/05/19 12/05 16:25 12/05/19 16:25 Earnings	Cooper Companies reports Q4 EPS $3.30, consensus $3.27 » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 12 Dec 13 Dec

Events

Earnings calls, analyst events, roadshows and more

SAIC
Today at 17:00

SAIC - SAIC Conference Calls
ZUMZ
Today at 17:00

Zumiez - ZUMZ Conference Calls
BIIB
Today at 17:00

Biogen - BIIB Conference Calls
PD
Today at 17:00

PagerDuty - PD Conference Calls
EZPW
Today at 17:00

Ezcorp - EZPW Conference Calls
ZUO
Today at 17:00

Zuora - ZUO Conference Calls
ULTA
Today at 17:00

Ulta Beauty - ULTA Conference Calls
GWRE
Today at 17:00

Guidewire - GWRE Conference Calls
CRWD
Today at 17:00

Crowdstrike - CRWD Conference Calls
COO
Today at 17:00

Cooper Companies - COO Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	ELF X ELF e.l.f. Beauty Block Trade Managers: Morgan Stanley Priced at: $15.90 3.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AER X AER AerCap Spot Secondary Managers: Citi Priced at: $60.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CWEN X CWEN Clearway Energy Spot Secondary Managers: RBC Capital Priced at: $18.70 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FSV X FSV FirstService Spot Secondary Managers: BMO Capital & TD Securities Priced at: $92.50 2.165M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ARWR X ARWR Arrowhead Secondary Managers: Goldman Sachs, Jefferies, Piper Jaffray & Cantor Fitzgerald, Baird, B. Riley FBR Priced at: $58.00 4M Shares KOD X KOD Kodiak Sciences Secondary Managers: JPMorgan, Goldman Sachs & Jefferies Priced at: $46.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRAY X VRAY ViewRay Secondary Managers: Piper Jaffray Priced at: $3.13 41.55M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNNE X CNNE Cannae Holdings Spot Secondary Managers: BofA/Merrill & Stephens Priced at: $33.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLMD X RLMD Relmada Therapeutics Spot Secondary Managers: Jefferies, SVB Leerink & Guggenheim Priced at: $30.00 3.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RVNC X RVNC Revance Spot Secondary Managers: Cowen, Piper Jaffray & Stifel Priced at: $17.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	LMPX X LMPX LMP Automotive IPO Managers: ThinkEquity Priced at: $5.00 2.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCC X CCC Clarivate Analytics Secondary Managers: Citi & Goldman Sachs Priced at: $17.25 43.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMMU X IMMU Immunomedics Secondary Managers: Goldman Sachs, BofA/Merrill, Cowen & Jefferies Priced at: $17.50 14.29M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUFN X TUFN Tufin Secondary Managers: JPMorgan, Barclays & Jefferies, Oppenheimer, Baird, Piper Jaffray, Stifel, William Blair Priced at: $17.00 4.28M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARDX X ARDX Ardelyx Spot Secondary Managers: Citi, Cowen, SVB Leerink & Piper Jaffray Priced at: $6.25 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MLND X MLND Millendo Therapeutics Spot Secondary Managers: Citi & SVB Leerink Priced at: $6.00 4.167M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NJR X NJR New Jersey Resources Spot Secondary Managers: Wells Fargo & JPMorgan, BBNT, TD Securities, Goldman Sachs, Janney Montgomery Scott, Siebert Williams Priced at: $41.25 5.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OMER X OMER Omeros Spot Secondary Managers: Cantor Fitzgerald Priced at: $13.10 3.816M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RC X RC Ready Capital Spot Secondary Managers: Morgan Stanley, UBS, Wells Fargo & Keefe Bruyette Priced at: $15.58 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial WHF X WHF WhiteHorse Finance Spot Secondary Managers: Raymond James, Keefe Bruyette & Deutsche Bank, Ladenburg, Oppenheimer, B. Riley FBR, National Securities Priced at: $13.83 2.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	EVRI X EVRI Everi Holdings Secondary Managers: Jefferies, Stifel, Craig-Hallum & Raymond James, SunTrust Priced at: $11.25 10M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $13.25 11.18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVOP X EVOP EVO Payments Spot Secondary Managers: JPMorgan & Barclays Priced at: $27.60 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	DT X DT Dynatrace Secondary Managers: Goldman Sachs, JPMorgan, Citi, RBC Capital, BofA/Merrill, Barclays, UBS & Jefferies, Canaccord, WBLR BTIG, JMP Securities, KeyBanc, Raymond James, Academy Securities $27.02 27.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GDS X GDS GDS Holdings Secondary Managers: JPMorgan, RBC Capital & BofA/Merrill, Haitong International $45.27 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Secondary Managers: Morgan Stanley & Barclays $3.80 40M Shares TTEC X TTEC TTEC Holdings Secondary Managers: BofA/Merrill, Morgan Stanley, Cowen, Craig-Hallum & William Blair, Northland, HSBC $44.71 3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ISEE X ISEE IVERIC bio Spot Secondary Managers: Cowen $4.30 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Sprint CEO says merging with T-Mobile 'best outcome for all consumers'

TODAY'S FREE FLY STORIES

Get Full Fly Access